Sarepta therapeutics announces fda approval of elevidys, the first gene therapy to treat duchenne muscular dystrophy

Cambridge, mass.--(business wire)--sarepta therapeutics announces the fda approval of elevidys, the first gene therapy approved to treat duchenne muscular dystrophy.

SRPT Ratings Summary

SRPT Quant Ranking